Skip to main content
SpringerLink
Log in

Acute Lymphoblastic Leukemia

  • Chapter
Book cover Cancer in Adolescents and Young Adults

Part of the book series: Pediatric Oncology ((PEDIATRICO))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bleyer WA, O’Leary M, Barr R, Ries LAG (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD, p 220

    Google Scholar 

  2. Stock W, Satner H, Dodge RK, et al. (2000) Outcome of adolescents and young adults with ALL: a comparison of Children’s Cancer Group (CCG) and Cancer and Acute Leukemia Group B (CALGB) regimens. Blood 96:467a

    Google Scholar 

  3. Boissel N, Auclerc MF, Lheritier V, et al (2003) Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 21:774–780

    Article  PubMed  Google Scholar 

  4. Testi AM, Valsecchi MG, Conter V, et al (2004) Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols. Blood 104:539a

    Google Scholar 

  5. de Bont JM, van der Holt B, Dekker AW, et al (2003) Significant difference in outcome for adolescents with acute lymphoblastic leukemia (ALL) treated on pediatric versus adult ALL protocols. Blood 102:222a

    Google Scholar 

  6. Ramanujachar R, Richards S, Hann IM, et al (2007) Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL 97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer, 48:254–261

    Article  PubMed  Google Scholar 

  7. Nachman J, Siebel N, Sather H, et al (2004) Outcome for adolescent and young adults 16–21 years of age (AYA) with acute lymphoblastic leukemia (ALL) treated on the Children’s Cancer Group (CCG) 1961 study. Blood 104:196a

    Google Scholar 

  8. Bhatia S, Ross JA, Greaves MF, Robison LL (1999) Epidemiology and etiology. In: Pui CH (ed) Childhood Leukemias. Cambridge University Press Cambridge, UK, p 41

    Google Scholar 

  9. Narod SA, Stiller C, Lenoir GM (1991) An estimate of the heritable fraction of childhood cancer. Br J Cancer 63:993–999

    PubMed  CAS  Google Scholar 

  10. Crispino JD (2005) GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 16:137–147

    Article  PubMed  CAS  Google Scholar 

  11. Hitzler JK, Zipursky A (2005) Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 5:11–20

    Article  PubMed  CAS  Google Scholar 

  12. Ge Y, Stout ML, Tatman DA, et al (2005) GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. J Natl Cancer Inst 97:226–231

    Article  PubMed  CAS  Google Scholar 

  13. Side L, Taylor B, Cayouette M, et al (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713–1720

    Article  PubMed  CAS  Google Scholar 

  14. Duker NJ (2002) Chromosome breakage syndromes and cancer. Am J Med Genet 115:125–129

    Article  PubMed  Google Scholar 

  15. Eyfjord JE, Bodvarsdottir SK (2005) Genomic instability and cancer: networks involved in response to DNA damage. Mutat Res 592:18–28

    PubMed  CAS  Google Scholar 

  16. Horwitz M, Li FQ, Albani D, et al (2003) Leukemia in severe congenital neutropenia: defective proteolysis suggests new pathways to malignancy and opportunities for therapy. Cancer Invest 21:579–587

    Article  PubMed  CAS  Google Scholar 

  17. Greaves MF (1988) Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 2:120–125

    PubMed  CAS  Google Scholar 

  18. Greaves MF, Alexander FE (1993) An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 7:349–360

    PubMed  CAS  Google Scholar 

  19. Greaves MF (1997) Aetiology of acute leukaemia. Lancet 349:344–349

    Article  PubMed  CAS  Google Scholar 

  20. Gilham C, Peto J, Simpson J, et al (2005) Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ 330:1294

    Article  PubMed  CAS  Google Scholar 

  21. Jourdan-Da Silva N, Perel Y, Méchinaud F, et al (2004) Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 90:139–145

    Article  PubMed  CAS  Google Scholar 

  22. Neglia JP, Linet MS, Shu XO, et al (2000) Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukemia. Br J Cancer 82:234–240

    Article  PubMed  CAS  Google Scholar 

  23. Chessells JM., Hall E, Prentice HG, et al (2004) The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 12:463–473

    Article  Google Scholar 

  24. Plasschaert SLA, Kamps WA, Vellenga E, et al (2004) Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev 30:3–51

    Article  Google Scholar 

  25. Pieters R, Den Boer ML, Durian M, et al. (1998) Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia — implications for treatment of infants. Leukemia 12:1344–1348

    Article  PubMed  CAS  Google Scholar 

  26. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, et al. (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104:2492–2498

    Article  PubMed  CAS  Google Scholar 

  27. Linker C, Damon L, Ries C, Navarro W (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol 20:2464–2471

    Article  PubMed  CAS  Google Scholar 

  28. Kantarijian H, Thomas D, O’Brien S, et al. (2004) Longterm follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 101:2788–2801

    Article  CAS  Google Scholar 

  29. Eden OB, Harrison G, Richards S, et al. (2000) on behalf of the Medical Research Council Childhood Leukaemia Working Party Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia. Leukemia 14:1980–1997

    Article  CAS  Google Scholar 

  30. Gaynon PS, Trigg ME, Heerema NA, et al. (2000) Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 14:2223–2233

    Article  PubMed  CAS  Google Scholar 

  31. Harms DO, Janka-Schaub GE on behalf of the COALL Study Group (2000) Co operative study group for childhood acute lymphoblastic leukemia (COALL): longterm follow-up of trials 82, 85, 89 and 92. Leukemia 14:2234–2239

    Article  PubMed  CAS  Google Scholar 

  32. Kamps WA, Veerman AJP, Van Wering ER, et al (2000) Long-term follow-up of Dutch childhood leukemia study group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991. Leukemia 14:2240–2246

    Article  PubMed  CAS  Google Scholar 

  33. Maloney KW, Shuster JJ, Murphy S, et al (2000) Longterm results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Leukemia 12:2276–2285

    Article  CAS  Google Scholar 

  34. Pui CH, Boyett JM, Rivera GK, et al. (2000) Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic at St. Jude Children’s Research Hospital. Leukemia 14:2286–2294

    Article  PubMed  CAS  Google Scholar 

  35. Schrappe M, Reiter A, Zimmermann M, et al. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 14:2205–2222

    Article  PubMed  CAS  Google Scholar 

  36. Silverman LB, Declerck L, Gelber RD, et al. (2000) Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995). Leukemia 14:2247–2256

    Article  PubMed  CAS  Google Scholar 

  37. Rubnitz JE, Lensing S, Zhou Y, et al. (2004) Death during induction therapy and first remission of acute leukemia in childhood. Cancer 101:1677–1684

    Article  PubMed  Google Scholar 

  38. Mattano LA, Sather HN, La MK, et al (2003) Modified dexamethasone (DXM) reduces the incidence of treatment-related osteonecrosis (ON) in children and adolescents with higher risk acute lymphoblastic leukemia (HR ALL): a report of CCG-1961. Blood 102:221a (abstract 777)

    Google Scholar 

  39. Mattano LA, Sather HN, Trigg ME, Nachman JB (2000) Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the children’s cancer group. J Clin Oncol 18:3262–3272

    PubMed  Google Scholar 

  40. Schiffer CA (2003) Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both? J Clin Oncol 21:760–761

    Article  PubMed  Google Scholar 

  41. Benjamin S, Kroll ME, Cartwright RA, et al (2000) Haematologists’ approaches to the management of adolescents and young adults with acute leukaemia. Br J Haematol 111:1045–1050

    Article  PubMed  CAS  Google Scholar 

  42. Seibel NL, Steinherz P, Sather H, et al (2003) Early treatment intensification improves outcome in children and adolescents with acute lymphoblastic leukemia presenting with unfavorable features who show a rapid early response to induction therapy: a report of CCG. Blood 102:A787

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wyler Children’s Hospital, University of Chicago Medical Center, 5841 South Maryland Ave, Chicago, IL, 60637, USA

    James Nachman M.D.

  2. Hospital San Gerardo, University of Milano-Bicocca, Via Perigolesi 33, 20052, Monza, Italy

    Giuseppe Masera M.D.

  3. St. Charles Medical Center, Bend, 2500 NE Neff Road, OR, 97701, USA

    W. Archie Bleyer M.D.

Authors
  1. James Nachman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Masera M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Archie Bleyer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Charles Medical Center, Bend, Oregon, USA

    W. Archie Bleyer

  2. McMaster University, Hamilton, Ontario, Canada

    Ronald D. Barr

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nachman, J., Masera, G., Archie Bleyer, W. (2007). Acute Lymphoblastic Leukemia. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68152-6_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40842-0

  • Online ISBN: 978-3-540-68152-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation